GlassScriptPhysician profile
Christopher R Walters
NPI 1053461319
$1,306.20
in general payments reported to CMS, 2019-2025
21 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $76.31 · 2021: $169 · 2022: $182 · 2023: $32.48 · 2024: $156 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $426.94 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $154.06 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $103.01 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $83.32 | 2021-2025 | Wegovy |
| Pfizer INC. | $82.74 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $67.56 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $56.65 | 2019-2024 | Camzyos, Eliquis |
| Amgen INC. | $47.23 | 2020-2022 | |
| Medtronic Vascular, INC. | $45.39 | 2019 | |
| Boston Scientific Corporation | $39.05 | 2019 | |
| Stryker Corporation | $35.98 | 2025 | Flowtriever |
| Abbott Laboratories | $28.70 | 2021 | |
| Esperion Therapeutics, INC. | $20.13 | 2021 | |
| Astellas Pharma US INC | $16.27 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $13.42 | 2019 | |
| Lemaitre Vascular, INC. | $11.90 | 2020 | |
| Kls-Martin L.P. | $6.46 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.